81 related articles for article (PubMed ID: 26044919)
21. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
[TBL] [Abstract][Full Text] [Related]
22. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of urinary growth hormone measurements in normal and short children according to different expressions of urinary growth hormone data.
Granada ML; Sanmartí A; Lucas A; Salinas I; Cuatrecasas JM; Foz M; Carrascosa A; Audí L
Pediatr Res; 1992 Jul; 32(1):73-6. PubMed ID: 1635848
[TBL] [Abstract][Full Text] [Related]
24. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone.
Albini CH; Sotos J; Sherman B; Johanson A; Celniker A; Hopwood N; Quattrin T; Mills BJ; MacGillivray MH
Pediatr Res; 1991 Jun; 29(6):619-22. PubMed ID: 1866220
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
Wu KH; Tsai FJ; Peng CT
Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
[TBL] [Abstract][Full Text] [Related]
27. Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.
Rauch F; Schnabel D; Seibel MJ; Remer T; Stabrey A; Michalk D; Schönau E
J Clin Endocrinol Metab; 1995 Apr; 80(4):1295-300. PubMed ID: 7714103
[TBL] [Abstract][Full Text] [Related]
28. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
29. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
Ranke MB; Schweizer R; Martin DD; Ehehalt S; Schwarze CP; Serra F; Binder G
Horm Res Paediatr; 2012; 77(4):214-21. PubMed ID: 22433161
[TBL] [Abstract][Full Text] [Related]
30. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder.
Tordjman S; Anderson GM; Bellissant E; Botbol M; Charbuy H; Camus F; Graignic R; Kermarrec S; Fougerou C; Cohen D; Touitou Y
Psychoneuroendocrinology; 2012 Dec; 37(12):1990-7. PubMed ID: 22613035
[TBL] [Abstract][Full Text] [Related]
31. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
[TBL] [Abstract][Full Text] [Related]
32. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
33. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children.
Quattrin T; Albini CH; Cara JF; Vandlen RL; Mills BJ; MacGillivray MH
J Clin Endocrinol Metab; 1988 Apr; 66(4):792-7. PubMed ID: 3346357
[TBL] [Abstract][Full Text] [Related]
35. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[TBL] [Abstract][Full Text] [Related]
36. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
[TBL] [Abstract][Full Text] [Related]
37. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
Feinberg MS; Scheinowitz M; Laron Z
Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
39. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
[TBL] [Abstract][Full Text] [Related]
40. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
